Medtronic

Medtronic is one of the world's largest medical device companies, with a broad portfolio spanning cardiac devices, surgical tools, diabetes management and neuroscience. Its diversification across therapies and geographies, combined with deep hospital relationships, gives it a resilient position in a market underpinned by aging populations and rising healthcare demand. Medtronic has raised its dividend for more than three decades, supported by steady device sales and recurring revenue. The yield is moderate and payout growth has slowed in recent years as the company works through pipeline and margin pressures. It offers a dependable, middle-of-the-road income profile rather than a standout one, best suited to patient, quality-focused holders.